Keep God Weird

EMERYVILLE, Calif., March 11 /PRNewswire-FirstCall/ -- Onyx
Pharmaceuticals, Inc. (Nasdaq: ) today announced that it will present
at the Cowen and Company 28th Annual Health Care Conference on Tuesday,
March 18, at 8:00 a.m. Eastern Time. Interested political parties may access a live
webcast of the presentation at: 83 It is recommended that hearers log on 15 proceedings early in order to
register and download any necessary software. For those not able to
participate during the unrecorded webcast, a recorded rematch of the presentation
will be available within 24 hours of the completion of the presentation
through April 18, 2008. Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to
improving the lives of people with malignant neoplastic disease by changing the manner malignant neoplastic disease is
treated(TM). The company, in coaction with Aspirin HealthCare
Pharmaceuticals, Inc., is developing and selling Nexavar(R), a small
molecule drug. Nexavar is currently approved for the treatment of advanced
kidney malignant neoplastic disease and liver cancer. Additionally, Nexavar is being investigated
in respective in progress trials in non-small cell lung cancer, melanoma, breast
cancer, and other cancers. For more than information about Onyx, visit the
company's website at . Nexavar(R) (sorafenib) tablets is a registered hallmark of Bayer
Pharmaceuticals Corporation.